Arcturus Therapeutics Ltd. Depreciation and Amortization Expense
Arcturus Therapeutics Ltd. reported Depreciation and Amortization Expense of $172.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2019-05-13
- Arcturus Therapeutics Ltd. depreciation, depletion and amortization, nonproduction for the quarter ending 2019-03-31 was $172.00K, a 54.95% increase year-over-year.
- Arcturus Therapeutics Ltd. depreciation, depletion and amortization, nonproduction for the quarter ending 2018-12-31 was $167.00K, a 53.21% increase year-over-year.
- Arcturus Therapeutics Ltd. depreciation, depletion and amortization, nonproduction for the quarter ending 2018-09-30 was $200.00K, a 100.00% increase year-over-year.
- Arcturus Therapeutics Ltd. depreciation, depletion and amortization, nonproduction for the quarter ending 2018-06-30 was $100.00K, a 0.00% change year-over-year.
- Arcturus Therapeutics Ltd. depreciation, depletion and amortization, nonproduction for fiscal 2018 was $582.00K, a 41.95% increase from fiscal 2017.
- Arcturus Therapeutics Ltd. depreciation, depletion and amortization, nonproduction for fiscal 2017 was $410.00K.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|
| 2019-03-31 | $172.00K 10-Q · filed 2019-05-13 | $339.00K derived: sum of 2 quarters · filed 2019-05-13 | $539.00K derived: sum of 3 quarters · filed 2019-05-13 | $639.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-12-31 | $167.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $367.00K derived: sum of 2 quarters · filed 2019-03-18 | $467.00K derived: sum of 3 quarters · filed 2019-03-18 | $582.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $200.00K 6-K · filed 2018-11-07 | $300.00K derived: sum of 2 quarters · filed 2018-11-07 | $415.00K 6-K · filed 2018-11-07 | $520.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-06-30 | $100.00K 6-K · filed 2018-09-28 | $256.00K 6-K · filed 2018-09-28 | $320.00K derived: sum of 3 quarters · filed 2019-05-13 | $420.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-03-31 | $111.00K 10-Q · filed 2019-05-13 | $220.00K derived: sum of 2 quarters · filed 2019-05-13 | $320.00K derived: sum of 3 quarters · filed 2019-05-13 | $420.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $109.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $209.00K derived: sum of 2 quarters · filed 2019-03-18 | $309.00K derived: sum of 3 quarters · filed 2019-03-18 | $410.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | $100.00K 6-K · filed 2018-11-07 | $200.00K derived: sum of 2 quarters · filed 2018-11-07 | $301.00K 6-K · filed 2018-11-07 | |
| 2017-06-30 | $100.00K 6-K · filed 2018-09-28 | $199.00K 6-K · filed 2018-09-28 | ||
| 2016-12-31 | $294.00K 20-F · filed 2018-05-14 | |||
| 2015-12-31 | $192.00K 20-F · filed 2018-05-14 |